Florida’s largest cannabis company broadens TruPowder product line with the addition of two new flavors

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), Florida’s leading medical cannabis company, announced today the launch of two new flavors to the TruPowder line: Vanilla Cream and Lemon. The TruPowder flavors will be available in all dispensaries across Florida starting today.


TruPowder is a Nano-encapsulated Cannabinoid powder. Using cutting edge and state of the art technology TruPowder uses sound waves (sonication) to achieve incredibly small nano-sized Cannabinoids which are then encapsulated.

“Trulieve is excited to be launching our newest flavors of Vanilla Cream and Lemon to our TruPowder line. We are focused on delivering an exceptional and differentiated customer experience, and that includes offering the broadest selection of high-quality cannabis products,” said Trulieve CMO Valda Coryat. “Trulieve continues to be the leading source for both quality and accessibility, and were first to offer ingestible products in the state of Florida.  With our newest TruPowder flavors, that will further extend our variety of cannabis offerings for Florida patients.”

Patients looking to receive the powerful effects of oral medical cannabis with the onset time closer to inhalation medical cannabis may greatly enjoy TruPowder. The medical cannabis is controllable, discreet, and solvent-less, making it a powerful, fast-acting daytime relief to patients seeking to avoid smoking or vaporizing cannabis that lasts.

Research has shown that nano-sized medicines have increased bioavailability and quicker onset time than other more traditional oral medicines. Patients are strongly encouraged to start low and go slow – with the increased onset time and bioavailability, this is a powerful medicine.

As the state’s leading medical cannabis provider, Trulieve’s employees are experienced, knowledgeable, and eager to help patients. Trulieve encourages potential patients, as well as patients who are new to cannabis and to our wide array of products, to connect with the staff in-store or through the online chat feature to learn more.

In stores and online, patients will find Florida’s largest selection of THC and CBD products, available in a variety of delivery methods, including smokable cannabis, concentrates, tinctures, topical creams, vaporizers, and more. Trulieve also offers home delivery statewide for patients, and convenient in-store pick-up at its 56 dispensaries in locations across the state from Pensacola to Key West.

For more information, please visit www.Trulieve.com.

About Trulieve
Trulieve is a vertically integrated “seed-to-sale” company and is the first and largest fully licensed medical cannabis company in the State of Florida. Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve-branded stores (dispensaries) throughout the State of Florida, as well as directly to patients via home delivery. Trulieve also operates in California, Massachusetts, and Connecticut. Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF.

To learn more about Trulieve, visit www.Trulieve.com.

Cision View original content:http://www.prnewswire.com/news-releases/trulieve-debuts-additional-flavors-for-trupowder-product-line-301117443.html

SOURCE Trulieve Cannabis Corp.

News Provided by PR Newswire via QuoteMedia

Trading resumes in:

Company: Revive Therapeutics Ltd.

Keep reading... Show less

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES /

Revive Therapeutics Ltd. (” Revive ” or the ” Company “) (CSE:RVV) ( USA : RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it has entered into an amended agreement with Canaccord Genuity Corp. and Leede Jones Gable Inc. as the co-lead underwriters (collectively, the ” Underwriters “), to increase the size of its previously announced offering of units (the ” Equity Units “) at a price of $0.50 per Equity Unit. Under the amended terms, the Underwriters have agreed to purchase, on a bought deal basis, 40,000,000 Equity Units for gross proceeds to the Company of $20,000,000 (the ” Offering “). The over-allotment option granted to the Underwriters will proportionately increase to 15% of the Offering.

Keep reading... Show less

The new dispensary brings expanded access for patients in the growing communities of Central Florida

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 77th nationwide. The new, 5,100 sq. ft. location marks the Company’s first in Summerfield expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”).

The Company announced today that its board of directors have approved a private placement of up to 15,000,000 units at a price of $.40 per unit for gross proceeds of up to $6,000,000. Each unit will consist of one common share of the Company and one share purchase warrant. Each share purchase warrant will be exercisable to purchase an additional common share at a fixed price of $.45 per share for a period of one year from closing.

Keep reading... Show less

The following issues have been halted by IIROC:

Company: Revive Therapeutics Ltd.

Keep reading... Show less